연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
1407. Effect of multiple invasive foci on breast cancer outcomes according to the molecular subtypes: a report from the Korean Breast Cancer Society.
Moon HG1, Han W, Kim JY, Kim SJ, Yoon JH, Oh SJ, Yu JH, Noh DY.
Ann Oncol. 2013 Sep;24(9):2298-304. doi: 10.1093/annonc/mdt187. Epub 2013 May 23. Link
1406. Leptin as a potential target for estrogen receptor-positive breast cancer.
Yom CK1, Lee KM, Han W, Kim SW, Kim HS, Moon BI, Jeong KY, Im SA, Noh DY.
J Breast Cancer. 2013 Jun;16(2):138-45. doi: 10.4048/jbc.2013.16.2.138. Epub 2013 Jun 28. Link
1405. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
Kim JY1, Han W, Moon HG, Park IA, Ahn SK, Kim J, Lee JW, Kim T, Kim MK, Noh DY.
Clin Breast Cancer. 2013 Oct;13(5):385-91. doi: 10.1016/j.clbc.2013.04.005. Epub 2013 Jul 17. Link
1404. Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.
Jeong JC, Kim JE, Ryu JW, Joo KW, Kim HK.
Thromb Res. 2013 Nov;132(5):604-9. doi: 10.1016/j.thromres.2013.09.002. Epub 2013 Sep 6. Link
1403. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
Hong SK, Kim JE, Han KS, Kim HK.
Thromb Res. 2013 Sep;132(3):392-7. doi: 10.1016/j.thromres.2013.07.025. Epub 2013 Aug 3. Link
1402. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q, Kim JE, Hyun J, Han KS, Kim HK.
Thromb Res. 2013 Jul;132(1):e70-5. doi: 10.1016/j.thromres.2013.05.015. Epub 2013 Jun 13. Link
1401. Serum des-R prothrombin activation peptide fragment 2: a novel prognostic marker for disseminated intravascular coagulation.
Chung S, Kim JE, Kim HK, Yeon EH, Shin YS, Kim CW.
Thromb Res. 2013 Jun;131(6):547-53. doi: 10.1016/j.thromres.2013.04.015. Epub 2013 May 7. Link
1400. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
Youngwon N, Kim JE, Lim HS, Han KS, Kim HK.
Biomed Res Int. 2013;2013:856754. doi: 10.1155/2013/856754. Epub 2013 Feb 21. Link
1399. Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.
Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.
Am J Clin Pathol. 2013 Mar;139(3):370-9. doi: 10.1309/AJCPC5C4AGFRDKMX. Link
1398. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.
Blood Coagul Fibrinolysis. 2013 Mar;24(2):150-6. doi: 10.1097/MBC.0b013e32835aef6b. Link